Skip to Content Facebook Feature Image

China approves world's first invasive brain-computer interface medical device

China

China

China

China approves world's first invasive brain-computer interface medical device

2026-03-13 16:44 Last Updated At:22:27

China's National Medical Products Administration (NMPA) on Friday issued marketing approval for the world's first invasive brain-computer interface (BCI) medical device, offering new hope for patients with paralysis to restore hand function by using brain signals.

The new-to-the-world product fills a critical void in both the domestic and international medical landscape, according to the administration.

"The medical device, called 'implantable brain-computer interface system for hand motor function compensation', is designed for quadriplegic patients suffering from spinal cord injuries. It can assist patients in achieving hand grasping function. Listed in the Class III medical device catalog, it is also the world's first invasive BCI medical device to go to market. It fills a clinical gap both domestically and internationally, making a zero-to-one breakthrough for invasive BCI medical devices worldwide," said Peng Liang, deputy director of the First Evaluation Department in the Center for Medical Device Evaluation of the NMPA.

For patients with spinal cord injuries, especially those who have been injured for more than a year, the difficulty of neurological recovery is extremely high.

The new device might help more people reignite the hope for life, as China now has 3.74 million spinal injury patients, with 90,000 new cases annually.

"In China, the cumulative number of spinal injury patients has already exceeded 3.7 million, with 90,000 new patients added each year. This means an average of 10 new patients every hour. Globally, the cumulative number of such patients has reached 15 million, and those under 50 years old account for more than 70 percent," said Chen Liang, deputy director of the Neurosurgery Department of the Huashan Hospital Affiliated to Fudan University.

The device can acquire electroencephalogram signals without touching brain tissue or damaging neurons, minimizing surgical trauma while ensuring long-term stability and reliability.

Different from consumer-grade BCI products, BCI medical devices must possess corresponding core elements for clinical treatment and obtain rigorous approval by drug regulatory authorities.

"The most important feature of a BCI medical device is its ability to read and analyze brain signals in real-time and interact with external devices to achieve a medical purpose. BCI products without a medical purpose do not belong to the category of medical devices. Some medical devices, although they read brain signals, do not perform real-time analysis or interact with external devices. So they are not BCI medical devices," said Peng.

China approves world's first invasive brain-computer interface medical device

China approves world's first invasive brain-computer interface medical device

China approves world's first invasive brain-computer interface medical device

China approves world's first invasive brain-computer interface medical device

China approves world's first invasive brain-computer interface medical device

China approves world's first invasive brain-computer interface medical device

The 2026 China Business Report, released on Thursday by the American Chamber of Commerce in Shanghai (AmCham Shanghai), revealed a significant rebound in business confidence among its surveyed member companies operating in China.

Business confidence bounced back markedly, as 58 percent of respondents expressed optimism about China's five-year business outlook, up 17 percentage points year on year, the report said.

Profitability rebounded to its highest level since 2019, with 78 percent of respondents profitable in 2025, an increase of 7 percentage points from the 2024 level, according to the report.

As business confidence rebounded and more companies reported profits, investment confidence in China also strengthened, resulting in 28 percent of respondents increasing investment in China last year, the highest level in four years.

Improved market sentiment is also reflected in a positive assessment of China's business environment. Fifty-five percent of surveyed companies said the business environment in China is transparent, up 7 percentage points year on year.

Jeffrey Lehman, chair of AmCham Shanghai, attributed the positive change to eased bilateral tensions and shared expectations for more stable and reciprocal economic and trade relationship, as the two leaders of states reaffirmed multiple times in the past year.

"We do our surveys In June, and so in June of 2025, there was a lot of anxiety among our members about the geopolitical situation. After that, we had the meeting of the leaders in Busan. We had the summit in Beijing in May, the agreement between the two countries that they would try to create a constructive relationship of strategic stability based on fairness and reciprocity. And that is very reassuring to our members because that suggests that there will be a stable environment in which they can operate well. If anxiety about geopolitics slips, that means then, that the number one concern is the continuing improvement in the quality of domestic competition," he said.

The report is based on AmCham Shanghai's 2026 China Business Survey of 262 member companies.

AmCham Shanghai report shows sharp rebound in business confidence among member companies

AmCham Shanghai report shows sharp rebound in business confidence among member companies

Recommended Articles